Editing Sleep disorder (section)

=== Obstructive sleep apnea ===
[[Obstructive sleep apnea]] (OSA) affects around 4% of men and 2% of women in the United States.<ref name=":2">{{cite journal | vauthors = Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM | title = Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature | journal = BMC Pulmonary Medicine | volume = 13 | pages = 10 | date = February 2013 | pmid = 23433391 | pmc = 3585751 | doi = 10.1186/1471-2466-13-10 | doi-access = free }}</ref> In general, this disorder is more prevalent among men. However, this difference tends to diminish with age. Women experience the highest risk for OSA during pregnancy,<ref name=":0">{{cite journal | vauthors = Wimms A, Woehrle H, Ketheeswaran S, Ramanan D, Armitstead J | title = Obstructive Sleep Apnea in Women: Specific Issues and Interventions | journal = BioMed Research International | volume = 2016 | pages = 1764837 | date = 2016 | pmid = 27699167 | pmc = 5028797 | doi = 10.1155/2016/1764837 | doi-access = free }}</ref> and tend to report experiencing [[Depression (mood)|depression]] and [[insomnia]] in conjunction with obstructive sleep apnea.<ref name=":3">{{cite journal | vauthors = Valipour A | title = Gender-related differences in the obstructive sleep apnea syndrome | journal = Pneumologie | volume = 66 | issue = 10 | pages = 584–588 | date = October 2012 | pmid = 22987326 | doi = 10.1055/s-0032-1325664 | doi-access = free }}</ref>

In a meta-analysis of the various Asian countries, India and China present the highest prevalence of the disorder. Specifically, about 13.7% of the Indian population and 7% of Hong Kong's population is estimated to have OSA. The two groups in the study experience daytime OSA symptoms such as difficulties concentrating, mood swings, or high blood pressure,<ref>{{Cite web|url=https://www.mayoclinic.org/diseases-conditions/obstructive-sleep-apnea/symptoms-causes/syc-20352090|title=Obstructive sleep apnea – Symptoms and causes – Mayo Clinic|website=www.mayoclinic.org|access-date=2017-11-27}}</ref> at similar rates (prevalence of 3.5% and 3.57%, respectively).<ref name=":2" />